Verition Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.53M Buy
7,200
+3,300
+85% +$1.18M 0.02% 898
2025
Q4
$1.28M Sell
3,900
-11,500
-75% -$3.65M 0.01% 1966
2025
Q3
$4.35M Buy
15,400
+2,800
+22% +$812K 0.02% 1299
2025
Q2
$3.52M Buy
12,600
+5,300
+73% +$1.5M 0.02% 1464
2025
Q1
$2.27M Buy
+7,300
New +$2.16M 0.01% 1478
2024
Q3
Sell
-1,500
Closed -$469K 3158
2024
Q2
$469K Buy
+1,500
New +$441K ﹤0.01% 2084
2023
Q1
Sell
-14,400
Closed -$3.78M 2135
2022
Q4
$3.78M Sell
14,400
-400
-3% -$107K 0.06% 409
2022
Q3
$3.34M Buy
+14,800
New +$3.59M 0.04% 619
2022
Q2
Sell
-19,200
Closed -$4.64M 2318
2022
Q1
$4.64M Buy
19,200
+7,400
+63% +$1.7M 0.06% 424
2021
Q4
$2.65M Buy
+11,800
New +$2.49M 0.02% 691

Other funds holding AMGN

Verition Fund Management's AMGN Position: Q1 2026 in Review

Verition Fund Management reduced its Amgen (AMGN) stake by 89% in Q1 2026, selling an estimated $13.5M and leaving 4,544 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #1124.

Verition Fund Management first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $15.2M in Q3 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Verition Fund Management held 4,544 shares of Amgen worth $1.6M as of Q1 2026.
  • Verition Fund Management sold 37,794 Amgen shares in Q1 2026, an estimated $13.5M.
  • Amgen made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1124 holding.
  • Verition Fund Management first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
  • Verition Fund Management's Amgen position peaked at $15.2M in Q3 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.